Navigating the Challenges of Gastroenterology Research
From inflammatory bowel disease (IBD) to irritable bowel syndrome (IBS), ulcerative colitis, and Crohn’s disease, gastrointestinal disorders affect millions and are growing in global prevalence. Yet, despite therapeutic innovation, gastroenterology trials remain difficult to recruit and retain patients for—due to symptom variability, invasive screening requirements, and geographic dispersion of eligible participants.
OMNI CRS helps solve these challenges—combining data and technology to accelerate recruitment and deliver reliable results across the spectrum of gastrointestinal research.
Accelerating Gastroenterology Enrollment With Precision Recruitment
We are more than a referral vendor—we are a strategic recruitment partner. Our proprietary performance-marketing engine leverages multi-channel outreach, automated pre-screening, and real-time data analysis to reach and engage qualified patients faster.
With experience across 35+ therapeutic areas and 150+ indications, OMNI CRS has supported campaigns in digestive health, metabolic syndromes, autoimmune disorders, and chronic inflammatory conditions—delivering both scale and specificity
Our Impact in Gastroenterology Clinical Trial Recruitment
Working with OmniCRS delivers measurable outcomes:
Proven recruitment
Across IBD, IBS, GERD, and ulcerative colitis
High match accuracy
Through data-validated pre-screening and adaptive targeting
Diverse enrollment pipelines
Ensuring representation across demographic groups
Across OMNI’s campaigns, 832,000+ qualified leads have been generated—demonstrating unmatched reach and scalability. Our performance-marketing approach has powered enrollment for both rare and high-volume digestive trials, reducing timelines and increasing retention
How OMNI CRS Delivers Exceptioal Patient Enrollment
Multi-Channel Outreach
We combine targeted digital campaigns, social media, provider referrals, and patient advocacy partnerships to connect eligible individuals with active research sites—no matter where they are located.
Predictive Data & Pre-Screening
Our AI-enabled tools identify, qualify, and validate participants using inclusion/exclusion algorithms tailored to gastrointestinal protocols, reducing screen failures and improving enrollment efficiency.
Compliance & Transparency
We design culturally relevant campaigns that reach underrepresented populations affected by gastrointestinal disorders. Every process is backed by HIPAA, GDPR, and FDA compliance, ensuring safety, transparency, and ethical integrity.
Proprietary fraud-prevention • HIPAA / GDPR / FDA compliance • Continuous quality monitoring
Recruitment Results That Advance Gastroenterology Research
OMNI CRS has consistently outperformed industry averages—completing enrollment 30–40% faster and achieving lower screen-failure rates through adaptive recruitment models and site feedback loops.
By aligning data precision with human-centered communication, OMNI ensures patients are informed, comfortable, and retained through study completion. The result: efficient trials, stronger datasets, and faster delivery of new therapies to patients who need them most.
Partner With OMNI CRS to Improve Gastroenterology Trial Outcomes
Your gastroenterology trial deserves a recruitment partner that brings speed, precision, and compliance to every campaign. OMNI CRS delivers reliable, scalable enrollment solutions trusted by CROs, pharma, and sites nationwide.